Skip to main content
SpringerLink
Log in

Intravenous rt-PA versus endovascular therapy for acute ischemic stroke

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

The influence of baseline stroke severity on outcome makes comparisons between nonrandomized studies of intravenous and intra-arterial (IA) therapy problematic. Using pooled data from the placebo arms of randomized trials in acute ischemic stroke, we derived predictive functions for outcome. We then compared the outcomes from published trials to these functions. Net benefit was calculated by comparison of the individual study with the predicted outcome based on the therapeutic time window. Similar net benefit for IA therapy and intravenous therapy was found at 3 hours and 6 hours; a slight advantage for IA therapy was mitigated by an increase in mortality at 6 hours and by publication bias. No net benefit for IA therapy was shown in the time window greater than 6 hours. Conclusive evidence for the superiority of either therapy awaits prospective randomized trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581–1587.

    Article  Google Scholar 

  2. The Third International Stroke Trial (Thrombolysis). Available at http://www.dcn.ed.ac.uk/ist3. Accessed March 6, 2008.

  3. ECASS 3—The European Cooperative Acute Stroke Study. Available at http://www.ecass3.com. Accessed March 7, 2008.

  4. Davis SM, Donnan GA, Parsons MW, et al.: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7:299–309.

    Article  PubMed  Google Scholar 

  5. Lees KR, Zivin JA, Ashwood T, et al.: NXY-059 for acute ischemic stroke. N Engl J Med 2006, 354:588–600.

    Article  PubMed  CAS  Google Scholar 

  6. Shuaib A, Lees KR, Lyden P, et al.: NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007, 357:562–571.

    Article  PubMed  CAS  Google Scholar 

  7. Clark WM, Coull BM, Karukin M, et al.: Randomized trial of cervene, a kappa receptor-selective opioid antagonist, in acute ischemic stroke. J Stroke Cerebrovasc Dis 1996, 6:35–40.

    Article  PubMed  CAS  Google Scholar 

  8. Clark WM, Raps EC, Tong DC, Kelly RE: Cervene (nalmefene) in acute ischemic stroke: final results of a phase III efficacy study. The Cervene Stroke Study Investigators. Stroke 2000, 31:1234–1239.

    PubMed  CAS  Google Scholar 

  9. McDougall C, Clark W, Mayer T, et al.: The Penumbra Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in acute ischemic stroke. Paper presented at the International Stroke Conference. New Orleans, LA; February 22, 2008.

  10. Gobin YP, Starkman S, Duckwiler GR, et al.: MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004, 35:2848–2854.

    Article  PubMed  Google Scholar 

  11. Interventional Management of Stroke III. Available at http://www.ims3.org. Accessed March 7, 2008.

  12. del Zoppo GJ, Higashida RT, Furlan AJ, et al.: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998, 29:4–11.

    PubMed  Google Scholar 

  13. Furlan A, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: a randomized controlled trial. JAMA 1999, 282:2003–2011.

    Article  PubMed  CAS  Google Scholar 

  14. Uchino K, Billheimer D, Cramer SC: Entry criteria and baseline characteristics predict outcome in acute stroke trials. Stroke 2001, 32:909–916.

    PubMed  CAS  Google Scholar 

  15. Weimar C, Konig IR, Kraywinkel K, et al.: Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004, 35:158–162.

    Article  PubMed  CAS  Google Scholar 

  16. Adams HP Jr, Davis PH, Leira EC, et al.: Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53:126–131.

    PubMed  CAS  Google Scholar 

  17. Mandava P, Kent TA: Intra-arterial therapies for acute ischemic stroke. Neurology 2007, 68:2132–2139.

    Article  PubMed  Google Scholar 

  18. Mandava P, Kent TA: A method to predict stroke trial success based on pooled control arms [abstract 20]. Paper presented at International Stroke Conference. New Orleans, LA; February 22, 2008. Available at http://stroke.ahajournals.org/cgi/reprint/39/2/527.

  19. Zar JH: Biostatistical Analysis, edn 3. Upper Saddle River, NJ: Prentice-Hall; 1996:282–283.

    Google Scholar 

  20. Beers KJ: Numerical Methods for Chemical Engineering. Applications in Matlab. Cambridge, UK: Cambridge University Press; 2007:81–85 and 225–230.

    Google Scholar 

  21. Mangiafico S, Cellerini M, Nencini P, et al.: Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intraarterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005, 26:2595–2601.

    PubMed  Google Scholar 

  22. Sterne JA, Egger M, Smith GD: Investigating and dealing with publication and other biases in metaanalysis. BMJ 2001, 323:101–105.

    Article  PubMed  CAS  Google Scholar 

  23. Hacke W, Kaste M, Fieschi C, et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768–774.

    Article  PubMed  Google Scholar 

  24. Alexandrov AV, Molina CA, Grotta JC, et al.: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004, 351:2170–2178.

    Article  PubMed  CAS  Google Scholar 

  25. Mori E, Tabuchi M, Yoshida T, Yamadori A: Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988, 19:802–812.

    PubMed  CAS  Google Scholar 

  26. Ezura M, Kagawa S: Selective and superselective infusion of urokinase for embolic stroke. Surg Neurol 1992, 38:353–358.

    Article  PubMed  CAS  Google Scholar 

  27. Ogawa A, Mori E, Minematsu K, et al.: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007, 38:2633–2639.

    Article  PubMed  CAS  Google Scholar 

  28. Adams HP, Leclerc JR, Bluhmki E, et al.: Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004, 18:124–129.

    Article  PubMed  Google Scholar 

  29. Quast MJ, Huang NC, Hillman GR, Kent TA: The evolution of acute stroke recorded by multimodal magnetic resonance imaging. Magn Reson Imaging 1993, 11:465–471.

    Article  PubMed  CAS  Google Scholar 

  30. Albers GW, Thijs VN, Wechsler L, et al.: Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60:508–517.

    Article  PubMed  Google Scholar 

  31. Becker KJ, Brott TG: Approval of the MERCI clot retriever: a critical view. Stroke 2005, 36:400–403.

    Article  PubMed  Google Scholar 

  32. Wechsler LR: Does the Merci Retriever work? Against. Stroke 2006, 37:1341–1342.

    Article  PubMed  Google Scholar 

  33. Ciccone A, Valvassori L, Gasparotti R, et al.: Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 2007, 38:2191–2195.

    Article  PubMed  Google Scholar 

  34. Pancioli AM: The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke (the CLEAR Stroke Trial): final results from Tier I and II [abstract 15]. Paper presented at International Stroke Conference. New Orleans LA; February 22, 2008. Available at http://stroke.ahajournals.org/cgi/reprint/39/2/527.

  35. Mandava P, Thiagarajan P, Kent TA: GP IIB/IIIa inhibitors in acute ischemic stroke: current status and future directions. Drugs 2008 (in press).

  36. Lo EH, Broderick JP, Moskowitz MA: tPA and proteolysis in the neurovascular unit. Stroke 2004, 35:354–356.

    Article  PubMed  Google Scholar 

  37. Fischer U, Arnold M, Nedeltchev K, et al.: NIHSS score and arteriographic findings in acute ischemic stroke. Stroke 2005, 36:2121–2125.

    Article  PubMed  Google Scholar 

  38. Walton M; Food and Drug Administration Division of Clinical Trial Design and Analysis: Clinical review for PLA 96–350. Available at http://www.fda.gov/cder/biologics/review/altegen061896r2.pdf. Accessed January 24, 2008.

  39. Lewandowski CA, Frankel M, Tomsick TA, et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30:2598–2605.

    PubMed  CAS  Google Scholar 

  40. Bourekas EC, Slivka AP, Shah R, et al.: Intraarterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery 2004, 54:39–44.

    Article  PubMed  Google Scholar 

  41. Sekoranja L, Loulidi J, Yilmaz H, et al.: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke. A transcranial color-coded duplex sonography-guided pilot study. Stroke 2006, 37:1805–1809.

    Article  PubMed  Google Scholar 

  42. Zaidat OO, Slivka AP, Mohammed Y, et al.: Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. Stroke 2005, 36:1089–1090.

    Article  PubMed  Google Scholar 

  43. Kim DJ, Kim DI, Kim SH, et al.: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005, 47:616–621.

    Article  PubMed  Google Scholar 

  44. Flaherty ML, Woo D, Kissela B, et al.: Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005, 64:386–388.

    PubMed  CAS  Google Scholar 

  45. IMS Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004, 35:904–911.

    Article  Google Scholar 

  46. IMS II Trial Investigators: The interventional management of stroke (IMS) II Study. Stroke 2007, 38:2127–2135.

    Article  Google Scholar 

  47. Lee KY, Kim DI, Kim SH, et al.: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004, 25:1470–1475.

    PubMed  Google Scholar 

  48. Clark WM, Albers GW, Madden KP, Hamilton S: The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study: Thrombolytic Therapy in Acute Ischemic Stroke Study investigators. Stroke 2000, 31:811–816.

    PubMed  CAS  Google Scholar 

  49. Hacke W, Kaste M, Fieschi C, et al.: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352:1245–1251.

    Article  PubMed  CAS  Google Scholar 

  50. Hu HH, Teng MM, Hsu L, et al.: A pilot study of a new thrombolytic agent for acute ischemic stroke in Taiwan within a five-hour window. Stroke 2006, 37:918–919.

    Article  PubMed  CAS  Google Scholar 

  51. Arnold M, Schroth G, Nedeltchev K, et al.: Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002, 33:1828–1833.

    Article  PubMed  Google Scholar 

  52. Zaidat OO, Suarez JI, Santillan C, et al.: Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002, 33:1821–1826.

    Article  PubMed  CAS  Google Scholar 

  53. Lee DH, Jo KD, Kim HG, et al.: Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 2002, 13:769–774.

    Article  PubMed  Google Scholar 

  54. Nakano S, Iseda T, Yoneyama T, et al.: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke 2002, 33:2872–2876.

    Article  PubMed  Google Scholar 

  55. Ueda T, Sakaki S, Kumon Y, Ohta S: Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30:2360–2365.

    PubMed  CAS  Google Scholar 

  56. Arnold M, Nedeltchev K, Mattle HP, et al.: Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions. J Neurol Neurosurg Psychiatry 2003, 74:739–742.

    Article  PubMed  CAS  Google Scholar 

  57. Jahan R, Duckwiler GR, Kidwell CS, et al.: Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol 1999, 20:1291–1299.

    PubMed  CAS  Google Scholar 

  58. Imai K, Mori T, Izumoto H, et al.: Clot removal therapy by aspiration and extraction for acute embolic carotid occlusion. AJNR Am J Neuroradiol 2005, 27:1521–1527.

    Google Scholar 

  59. Qureshi AI, Siddiqui AM, Suri MF, et al.: Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002, 51:1319–1327.

    Article  PubMed  Google Scholar 

  60. Sorimachi T, Fuji Y, Tsuchiya N, et al.: Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol 2004, 25:1391–1402.

    PubMed  Google Scholar 

  61. Keris V, Rudnicka S, Vorona V, et al.: Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2001, 22:352–358.

    PubMed  CAS  Google Scholar 

  62. Suarez JI, Sunshine JL, Tarr R, et al.: Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999, 30:2094–2100.

    PubMed  CAS  Google Scholar 

  63. Ostrem JL, Saver JL, Alger JR, et al.: Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004, 35:e30–e34.

    Article  PubMed  Google Scholar 

  64. Arnold M, Nedeltchev K, Schroth G, et al.: Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004, 75:857–862.

    Article  PubMed  CAS  Google Scholar 

  65. Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36:1432–1438.

    Article  PubMed  Google Scholar 

  66. Smith WS, Sung G, Saver J, et al.: Mechanical thrombectomy for acute ischemic stroke. Final results of the Multi MERCI trial. Stroke 2008, 39:1205–1212.

    Article  PubMed  Google Scholar 

  67. Mahon BR, Nesbit GM, Barnwell SL, et al.: North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke. AJNR Am J Neuroradiol 2003, 24:534–538.

    PubMed  Google Scholar 

  68. Kim D, Jahan R, Starkman S, et al.: Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR Am J Neuroradiol 2006, 27:2048–2052.

    PubMed  CAS  Google Scholar 

  69. Bergui M, Stura G, Daniele D, et al.: Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment. Stroke 2006, 37:145–150.

    Article  PubMed  Google Scholar 

  70. Eckert B, Koch C, Thomalla G, et al.: Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005, 36:1160–1165.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Baylor College of Medicine/MEDVAMC, 2002 Holcombe Blvd (127), Houston, TX, 77030, USA

    Thomas A. Kent

Authors
  1. Pitchaiah Mandava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose I. Suarez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas A. Kent
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas A. Kent.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandava, P., Suarez, J.I. & Kent, T.A. Intravenous rt-PA versus endovascular therapy for acute ischemic stroke. Curr Atheroscler Rep 10, 332–338 (2008). https://doi.org/10.1007/s11883-008-0051-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-008-0051-x

Keywords

Search

Navigation